Almac Group’s Bold Leap: Wind Power Deal Cuts Emissions, Aims for 2045 Net-Zero Target


Almac Group Commits to Major Carbon Emission Reductions with Wind Energy Deal

In a significant move towards sustainability, Almac Group, a leader in the pharmaceutical and biotech services industry, has announced a 15-year virtual power purchase agreement (VPPA) with NTR plc. This partnership is aimed at supporting renewable energy generation from the Murley wind farm in Northern Ireland.

By tapping into the 21.6MW wind project, Almac is set to reduce its global scope 2 carbon emissions by 46%, with a notable reduction of over 95% at its Global Headquarters in Craigavon. The wind farm, which consists of six turbines capable of producing 34GWh of renewable electricity annually, is expected to be fully operational by July 2024.

This initiative is part of Almac’s ambitious goal to achieve net-zero emissions by 2045, further highlighted by its participation in the Science Based Targets Initiative (SBTi). Niall Harkin, Executive Director of Almac Group, expressed pride in this achievement, emphasizing its significance in the company’s environmental journey and the broader drug development industry’s move towards sustainable practices.

The commitment by Almac Group to significantly cut its carbon footprint and invest in renewable energy sources marks a pivotal moment in the pharmaceutical sector’s ongoing shift towards environmental responsibility.